Exact Mass: 586.3188

Exact Mass Matches: 586.3188

Found 71 metabolites which its exact mass value is equals to given mass value 586.3188, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Inuline

Anthranoyllycoctonine

C32H46N2O8 (586.3254)


   

all-trans-Hexaprenyl diphosphate

[({[(2E,6E,10E,14E,18E)-3,7,11,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaen-1-yl]oxy}(hydroxy)phosphoryl)oxy]phosphonic acid

C30H52O7P2 (586.3188)


all-trans-Hexaprenyl diphosphate is the final product of the hexaprenyl diphosphate biosynthesis pathway. In this pathway, multiple units of isopentenyl diphosphate (IPP) undergo a series of polymerizations to form various polyisoprenoids. There are two different pathways for the biosynthesis of IPP. Bacteria that possess ubiquinone generally use the methylerythritol phosphate pathway (MEP), while the eukaryotic microorganisms use the mevalonate pathway. However, exceptions exist. For example, some eukaryotic microbes, like the green algae and the malarial parasite Plasmodium falciparum, appear to utilize the MEP pathway, and some bacteria utilize the mevalonate pathway (Eisenreich01, Eisenreich04). In Saccharomyces cerevisiae S288C, the initial addition of two isoprenyl units to form (E, E)-farnesyl diphosphate is catalyzed by geranyltransferase / dimethylallyltransferase, encoded by FPP1. An additional unit is added by farnesyltranstransferase (encoded by BTS1), resulting in the formation of all-trans-geranyl-geranyl diphosphate. The last enzyme in this pathway is hexaprenyl diphosphate synthase (encoded by COQ1), which adds additional isoprenoid units to a maximal length unique to the organism. In the case of Saccharomyces cerevisiae S288C, it is 6 units. Polyprenyl diphosphate synthase enzymes, such as hexaprenyl diphosphate synthase, are responsible for determining the final length of the tail. When yeast COQ1 mutants are complemented with homologs from other organisms, ubiquinone biosynthesis is restored, but the tail length of the quinone depends on the source of the enzyme. All-trans-hexaprenyl diphosphate is the final product of hexaprenyl diphosphate biosynthesis pathway.In this pathway multiple units of isopentenyl diphosphate (IPP) undergo a series of polymerizations to form various polyisoprenoids.

   

Presqualene diphosphate

[({[(1S,2S,3S)-2-[(3E)-4,8-dimethylnona-3,7-dien-1-yl]-2-methyl-3-[(1E,5E)-2,6,10-trimethylundeca-1,5,9-trien-1-yl]cyclopropyl]methoxy}(hydroxy)phosphoryl)oxy]phosphonic acid

C30H52O7P2 (586.3188)


Presqualene diphosphate is an intermediate in the biosynthesis of Terpenoid. It is a substrate for Farnesyl-diphosphate farnesyltransferase. [HMDB]. Presqualene diphosphate is found in many foods, some of which are soft-necked garlic, pomes, roman camomile, and white cabbage. Presqualene diphosphate is an intermediate in the biosynthesis of Terpenoid. It is a substrate for Farnesyl-diphosphate farnesyltransferase.

   

5-Oxoavermectin 2b aglycone

5-Oxoavermectin 2b aglycone

C33H46O9 (586.3142)


   

ditrans,tricis-Hexaprenyl diphosphate

ditrans,tricis-Hexaprenyl diphosphate

C30H52O7P2 (586.3188)


   

Inuline

{11-ethyl-8,9-dihydroxy-4,6,16,18-tetramethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-13-yl}methyl 2-aminobenzoate

C32H46N2O8 (586.3254)


   

Methyl ganoderate H

Methyl ganoderate H

C33H46O9 (586.3142)


   

Lasonolide F

Lasonolide F

C33H46O9 (586.3142)


   

14-hydroxyplagiochiline-A-15-yl 2E,4E,8Z-tetradecatrienoate

14-hydroxyplagiochiline-A-15-yl 2E,4E,8Z-tetradecatrienoate

C33H46O9 (586.3142)


   
   
   

(4S,5S,6S,8S,9S,10R,13R,14S,16S,17Z)-6,16-diacetoxy-25-hydroxy-3,7-dioxo-29-nordammara-1,17(20)-dien-21-oic acid

(4S,5S,6S,8S,9S,10R,13R,14S,16S,17Z)-6,16-diacetoxy-25-hydroxy-3,7-dioxo-29-nordammara-1,17(20)-dien-21-oic acid

C33H46O9 (586.3142)


   

Anthranoyllycoctonine

Anthranoyllycoctonine

C32H46N2O8 (586.3254)


Origin: Plant; SubCategory_DNP: Terpenoid alkaloids, Diterpene alkaloid, Aconitum alkaloid Annotation level-1

   
   
   

GLRNQ

Gly-Leu-Arg-Asn-Gln

C23H42N10O8 (586.3187)


   

PI(17:0/0:0)

1-heptadecanoyl-glycero-3-phospho-(1-myo-inositol)

C26H51O12P (586.3118)


   

LPI 17:0

1-heptadecanoyl-glycero-3-phospho-(1-myo-inositol)

C26H51O12P (586.3118)


   

Presqualene diphosphate

Presqualene diphosphate

C30H52O7P2 (586.3188)


A triterpenyl phosphate that is presqualene in which the hydroxy hydrogen has been replaced by a diphosphate group.

   

All-trans-hexaprenyl diphosphate

(2E,6E,10E,14E,18E)-3,7,11,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaen-1-yl trihydrogen diphosphate

C30H52O7P2 (586.3188)


   

ethane-1,2-diol,hexanedioic acid,2-hydroxyethyl prop-2-enoate,1-isocyanato-4-[(4-isocyanatocyclohexyl)methyl]cyclohexane

ethane-1,2-diol,hexanedioic acid,2-hydroxyethyl prop-2-enoate,1-isocyanato-4-[(4-isocyanatocyclohexyl)methyl]cyclohexane

C28H46N2O11 (586.3101)


   

6beta,16beta-Diacetoxy-25-hydroxy-3,7-dioxy-29-nordammara-1,17(20)-dien-21-oic acid

6beta,16beta-Diacetoxy-25-hydroxy-3,7-dioxy-29-nordammara-1,17(20)-dien-21-oic acid

C33H46O9 (586.3142)


A tetracyclic triterpenoid that is 29-nordammara-1,17(20)-diene substituted by acetoxy groups at positions 6 and 16, a carboxy group at position 21, a hydroxy group at position 25 and oxo groups at positions 3 and 7 respectively. It is isolated from the marine-derived fungal strain Aspergillus sydowii PFW1-13 and exhibits antibacterial activity.

   

[(2Z,6Z,10Z,14Z,18E)-3,7,11,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaenyl] phosphono hydrogen phosphate

[(2Z,6Z,10Z,14Z,18E)-3,7,11,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaenyl] phosphono hydrogen phosphate

C30H52O7P2 (586.3188)


   

[(1S,2R,3S)-2-[(3E)-4,8-dimethylnona-3,7-dienyl]-2-methyl-3-[(1E,5E)-2,6,10-trimethylundeca-1,5,9-trienyl]cyclopropyl]methyl phosphono hydrogen phosphate

[(1S,2R,3S)-2-[(3E)-4,8-dimethylnona-3,7-dienyl]-2-methyl-3-[(1E,5E)-2,6,10-trimethylundeca-1,5,9-trienyl]cyclopropyl]methyl phosphono hydrogen phosphate

C30H52O7P2 (586.3188)


   

N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(1-naphthalenylamino)-oxomethyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclohexanecarboxamide

N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(1-naphthalenylamino)-oxomethyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclohexanecarboxamide

C34H42N4O5 (586.3155)


   

N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(1-naphthalenylamino)-oxomethyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclohexanecarboxamide

N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(1-naphthalenylamino)-oxomethyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclohexanecarboxamide

C34H42N4O5 (586.3155)


   

N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(1-naphthalenylamino)-oxomethyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclohexanecarboxamide

N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(1-naphthalenylamino)-oxomethyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclohexanecarboxamide

C34H42N4O5 (586.3155)


   

5-Oxoavermectin2b aglycone

5-Oxoavermectin 2b aglycone

C33H46O9 (586.3142)


   

[(4S,5R,6S,8R,10S,13S,16S,18S)-11-ethyl-8,9-dihydroxy-4,6,16,18-tetramethoxy-11-azahexacyclo[7.7.2.12,5.01,10.03,8.013,17]nonadecan-13-yl]methyl 2-aminobenzoate

[(4S,5R,6S,8R,10S,13S,16S,18S)-11-ethyl-8,9-dihydroxy-4,6,16,18-tetramethoxy-11-azahexacyclo[7.7.2.12,5.01,10.03,8.013,17]nonadecan-13-yl]methyl 2-aminobenzoate

C32H46N2O8 (586.3254)


   

[(1S,2R,3R,4S,5R,6S,8R,9S,10R,13S,16S,17R,18S)-11-ethyl-8,9-dihydroxy-4,6,16,18-tetramethoxy-11-azahexacyclo[7.7.2.12,5.01,10.03,8.013,17]nonadecan-13-yl]methyl 2-aminobenzoate

[(1S,2R,3R,4S,5R,6S,8R,9S,10R,13S,16S,17R,18S)-11-ethyl-8,9-dihydroxy-4,6,16,18-tetramethoxy-11-azahexacyclo[7.7.2.12,5.01,10.03,8.013,17]nonadecan-13-yl]methyl 2-aminobenzoate

C32H46N2O8 (586.3254)


   

[(1S,4S,5R,6S,8R,9S,13S,16R,18S)-11-ethyl-8,9-dihydroxy-4,6,16,18-tetramethoxy-11-azahexacyclo[7.7.2.12,5.01,10.03,8.013,17]nonadecan-13-yl]methyl 2-aminobenzoate

[(1S,4S,5R,6S,8R,9S,13S,16R,18S)-11-ethyl-8,9-dihydroxy-4,6,16,18-tetramethoxy-11-azahexacyclo[7.7.2.12,5.01,10.03,8.013,17]nonadecan-13-yl]methyl 2-aminobenzoate

C32H46N2O8 (586.3254)


   

[2-Hydroxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropyl] heptadecanoate

[2-Hydroxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropyl] heptadecanoate

C26H51O12P (586.3118)


   

[(2R)-1,1,2,3,3-pentadeuterio-2-hydroxy-3-[hydroxy-[(5R)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxypropyl] heptadecanoate

[(2R)-1,1,2,3,3-pentadeuterio-2-hydroxy-3-[hydroxy-[(5R)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxypropyl] heptadecanoate

C26H51O12P (586.3118)


   

[(2R)-1,1,3,3-tetradeuterio-2-hydroxy-3-[hydroxy-[(5R)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxypropyl] heptadecanoate

[(2R)-1,1,3,3-tetradeuterio-2-hydroxy-3-[hydroxy-[(5R)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxypropyl] heptadecanoate

C26H51O12P (586.3118)


   

1-heptadecanoyl-glycero-3-phospho-(1-myo-inositol)

1-heptadecanoyl-glycero-3-phospho-(1-myo-inositol)

C26H51O12P (586.3118)


   

hexaprenyl diphosphate

hexaprenyl diphosphate

C30H52O7P2 (586.3188)


A polyprenol diphosphate compound having six prenyl units with undefined stereochemistry about the double bonds.

   
   

PA P-18:0/9:4;O2

PA P-18:0/9:4;O2

C30H51O9P (586.3271)


   

PA P-20:1/7:3;O2

PA P-20:1/7:3;O2

C30H51O9P (586.3271)


   

PA 14:1/13:3;O

PA 14:1/13:3;O

C30H51O9P (586.3271)


   

PA 18:3/9:1;O

PA 18:3/9:1;O

C30H51O9P (586.3271)


   

PA 20:1/7:3;O

PA 20:1/7:3;O

C30H51O9P (586.3271)


   
   
   
   
   

ST 27:5;O3;GlcA

ST 27:5;O3;GlcA

C33H46O9 (586.3142)


   

ST 27:6;O4;Hex

ST 27:6;O4;Hex

C33H46O9 (586.3142)


   

[(1s,2r,3r,4s,5r,6s,8r,9r,10s,13s,16s,17r,18s)-11-ethyl-8,9-dihydroxy-4,6,16,18-tetramethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-13-yl]methyl 2-aminobenzoate

[(1s,2r,3r,4s,5r,6s,8r,9r,10s,13s,16s,17r,18s)-11-ethyl-8,9-dihydroxy-4,6,16,18-tetramethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-13-yl]methyl 2-aminobenzoate

C32H46N2O8 (586.3254)


   

(2s,3as,3bs,5s,5as,6s,9ar,9bs,11ar)-5-(acetyloxy)-1-[(6s)-6-(2-hydroxypropan-2-yl)-2-oxooxan-3-ylidene]-3a,3b,6,9a-tetramethyl-4,7-dioxo-decahydro-2h-cyclopenta[a]phenanthren-2-yl acetate

(2s,3as,3bs,5s,5as,6s,9ar,9bs,11ar)-5-(acetyloxy)-1-[(6s)-6-(2-hydroxypropan-2-yl)-2-oxooxan-3-ylidene]-3a,3b,6,9a-tetramethyl-4,7-dioxo-decahydro-2h-cyclopenta[a]phenanthren-2-yl acetate

C33H46O9 (586.3142)


   

{[(1s,2s,3s)-2-[(3e)-4,8-dimethylnona-3,7-dien-1-yl]-2-methyl-3-[(1e)-2,6,10-trimethylundeca-1,5,9-trien-1-yl]cyclopropyl]methoxy(hydroxy)phosphoryl}oxyphosphonic acid

{[(1s,2s,3s)-2-[(3e)-4,8-dimethylnona-3,7-dien-1-yl]-2-methyl-3-[(1e)-2,6,10-trimethylundeca-1,5,9-trien-1-yl]cyclopropyl]methoxy(hydroxy)phosphoryl}oxyphosphonic acid

C30H52O7P2 (586.3188)


   

anthranoyllycotonine

NA

C32H46N2O8 (586.3254)


{"Ingredient_id": "HBIN016292","Ingredient_name": "anthranoyllycotonine","Alias": "NA","Ingredient_formula": "C32H46N2O8","Ingredient_Smile": "CCN1CC2(CCC(C34C2C(C(C31)(C5(CC(C6CC4C5C6OC)OC)O)O)OC)OC)COC(=O)C7=CC=CC=C7N","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "30611","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

methyl (2r,6r)-6-[(1r,3ar,5ar,7s,9as,11s,11ar)-11-(acetyloxy)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-3,4,10-trioxo-1h,2h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoate

methyl (2r,6r)-6-[(1r,3ar,5ar,7s,9as,11s,11ar)-11-(acetyloxy)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-3,4,10-trioxo-1h,2h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoate

C33H46O9 (586.3142)


   

{11-ethyl-9,16-dihydroxy-4,6,8,18-tetramethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-13-yl}methyl 2-aminobenzoate

{11-ethyl-9,16-dihydroxy-4,6,8,18-tetramethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-13-yl}methyl 2-aminobenzoate

C32H46N2O8 (586.3254)


   

methyl (2r,6s)-6-[(1r,3ar,5as,7s,9as,11s,11ar)-11-(acetyloxy)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-3,4,10-trioxo-1h,2h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoate

methyl (2r,6s)-6-[(1r,3ar,5as,7s,9as,11s,11ar)-11-(acetyloxy)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-3,4,10-trioxo-1h,2h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoate

C33H46O9 (586.3142)


   

2-[(1z,2s,3as,3bs,5s,5as,6s,9ar,9bs,11ar)-2,5-bis(acetyloxy)-3a,3b,6,9a-tetramethyl-4,7-dioxo-2h,3h,5h,5ah,6h,9bh,10h,11h,11ah-cyclopenta[a]phenanthren-1-ylidene]-6-hydroxy-6-methylheptanoic acid

2-[(1z,2s,3as,3bs,5s,5as,6s,9ar,9bs,11ar)-2,5-bis(acetyloxy)-3a,3b,6,9a-tetramethyl-4,7-dioxo-2h,3h,5h,5ah,6h,9bh,10h,11h,11ah-cyclopenta[a]phenanthren-1-ylidene]-6-hydroxy-6-methylheptanoic acid

C33H46O9 (586.3142)


   

(4r,5r,8r)-9-formyl-2-({[(2r,3s,4s,5r,6r)-4-[(2e,4e)-hexa-2,4-dienoyloxy]-3-hydroxy-5-methoxy-6-methyloxan-2-yl]oxy}methyl)-13-isopropyl-5-methyltetracyclo[7.4.0.0²,¹¹.0⁴,⁸]tridec-12-ene-1-carboxylic acid

(4r,5r,8r)-9-formyl-2-({[(2r,3s,4s,5r,6r)-4-[(2e,4e)-hexa-2,4-dienoyloxy]-3-hydroxy-5-methoxy-6-methyloxan-2-yl]oxy}methyl)-13-isopropyl-5-methyltetracyclo[7.4.0.0²,¹¹.0⁴,⁸]tridec-12-ene-1-carboxylic acid

C33H46O9 (586.3142)


   

[(1s,2r,3r,4s,5r,6s,8r,9s,10s,13s,16r,17r,18s)-11-ethyl-8,9-dihydroxy-4,6,16,18-tetramethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-13-yl]methyl 2-aminobenzoate

[(1s,2r,3r,4s,5r,6s,8r,9s,10s,13s,16r,17r,18s)-11-ethyl-8,9-dihydroxy-4,6,16,18-tetramethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-13-yl]methyl 2-aminobenzoate

C32H46N2O8 (586.3254)


   

bis((5z)-1-acetyl-5-ethylidene-3-octanoylpyrrolidine-2,4-dione)

bis((5z)-1-acetyl-5-ethylidene-3-octanoylpyrrolidine-2,4-dione)

C32H46N2O8 (586.3254)


   

[(1s,4s,5r,6s,8r,9r,13s,16s,18s)-11-ethyl-8,9-dihydroxy-4,6,16,18-tetramethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-13-yl]methyl 2-aminobenzoate

[(1s,4s,5r,6s,8r,9r,13s,16s,18s)-11-ethyl-8,9-dihydroxy-4,6,16,18-tetramethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-13-yl]methyl 2-aminobenzoate

C32H46N2O8 (586.3254)


   

methyl (6r)-6-[(1r,3ar,5ar,7s,9as,11s,11ar)-11-(acetyloxy)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-3,4,10-trioxo-1h,2h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoate

methyl (6r)-6-[(1r,3ar,5ar,7s,9as,11s,11ar)-11-(acetyloxy)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-3,4,10-trioxo-1h,2h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoate

C33H46O9 (586.3142)


   

methyl 6-[11-(acetyloxy)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-3,4,10-trioxo-1h,2h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoate

methyl 6-[11-(acetyloxy)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-3,4,10-trioxo-1h,2h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoate

C33H46O9 (586.3142)


   

(2r,4z)-2-hydroxy-6-[(1r,4z,6e,9s,11s,12r,13r,14z,16z,19e,21s,23s,24s)-11-hydroxy-24-(hydroxymethyl)-12,15,24-trimethyl-3-oxo-2,22,26-trioxatricyclo[19.3.1.1⁹,¹³]hexacosa-4,6,14,16,19-pentaen-23-yl]hex-4-enoic acid

(2r,4z)-2-hydroxy-6-[(1r,4z,6e,9s,11s,12r,13r,14z,16z,19e,21s,23s,24s)-11-hydroxy-24-(hydroxymethyl)-12,15,24-trimethyl-3-oxo-2,22,26-trioxatricyclo[19.3.1.1⁹,¹³]hexacosa-4,6,14,16,19-pentaen-23-yl]hex-4-enoic acid

C33H46O9 (586.3142)


   

5-(acetyloxy)-1-[6-(2-hydroxypropan-2-yl)-2-oxooxan-3-ylidene]-3a,3b,6,9a-tetramethyl-4,7-dioxo-decahydro-2h-cyclopenta[a]phenanthren-2-yl acetate

5-(acetyloxy)-1-[6-(2-hydroxypropan-2-yl)-2-oxooxan-3-ylidene]-3a,3b,6,9a-tetramethyl-4,7-dioxo-decahydro-2h-cyclopenta[a]phenanthren-2-yl acetate

C33H46O9 (586.3142)


   

(3r,4r,7r)-8-formyl-2-({[(2r,3s,4s,5r,6r)-3-hydroxy-5-methoxy-6-methyl-4-{[(2z,4e)-2-methylhexa-2,4-dienoyl]oxy}oxan-2-yl]oxy}methyl)-12-isopropyl-4-methyltetracyclo[6.4.0.0²,¹⁰.0³,⁷]dodec-11-ene-1-carboxylic acid

(3r,4r,7r)-8-formyl-2-({[(2r,3s,4s,5r,6r)-3-hydroxy-5-methoxy-6-methyl-4-{[(2z,4e)-2-methylhexa-2,4-dienoyl]oxy}oxan-2-yl]oxy}methyl)-12-isopropyl-4-methyltetracyclo[6.4.0.0²,¹⁰.0³,⁷]dodec-11-ene-1-carboxylic acid

C33H46O9 (586.3142)


   

2-[2,5-bis(acetyloxy)-3a,3b,6,9a-tetramethyl-4,7-dioxo-2h,3h,5h,5ah,6h,9bh,10h,11h,11ah-cyclopenta[a]phenanthren-1-ylidene]-6-hydroxy-6-methylheptanoic acid

2-[2,5-bis(acetyloxy)-3a,3b,6,9a-tetramethyl-4,7-dioxo-2h,3h,5h,5ah,6h,9bh,10h,11h,11ah-cyclopenta[a]phenanthren-1-ylidene]-6-hydroxy-6-methylheptanoic acid

C33H46O9 (586.3142)


   

(4r,5r,8r)-9-formyl-2-({[(2r,3s,4s,5r,6r)-4-[(2z,4e)-hexa-2,4-dienoyloxy]-3-hydroxy-5-methoxy-6-methyloxan-2-yl]oxy}methyl)-13-isopropyl-5-methyltetracyclo[7.4.0.0²,¹¹.0⁴,⁸]tridec-12-ene-1-carboxylic acid

(4r,5r,8r)-9-formyl-2-({[(2r,3s,4s,5r,6r)-4-[(2z,4e)-hexa-2,4-dienoyloxy]-3-hydroxy-5-methoxy-6-methyloxan-2-yl]oxy}methyl)-13-isopropyl-5-methyltetracyclo[7.4.0.0²,¹¹.0⁴,⁸]tridec-12-ene-1-carboxylic acid

C33H46O9 (586.3142)


   

methyl (2s,6r)-6-[(1r,3ar,5ar,7s,9as,11s,11ar)-11-(acetyloxy)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-3,4,10-trioxo-1h,2h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoate

methyl (2s,6r)-6-[(1r,3ar,5ar,7s,9as,11s,11ar)-11-(acetyloxy)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-3,4,10-trioxo-1h,2h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoate

C33H46O9 (586.3142)


   

[(1s,2r,3r,4s,5r,6s,8r,9s,10s,13s,16s,17r,18s)-11-ethyl-8,9-dihydroxy-4,6,16,18-tetramethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-13-yl]methyl 2-aminobenzoate

[(1s,2r,3r,4s,5r,6s,8r,9s,10s,13s,16s,17r,18s)-11-ethyl-8,9-dihydroxy-4,6,16,18-tetramethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-13-yl]methyl 2-aminobenzoate

C32H46N2O8 (586.3254)


   

[(1s,2r,3r,4s,5r,6s,8r,9s,10s,13s,16s,17r,18s)-11-ethyl-9,16-dihydroxy-4,6,8,18-tetramethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-13-yl]methyl 2-aminobenzoate

[(1s,2r,3r,4s,5r,6s,8r,9s,10s,13s,16s,17r,18s)-11-ethyl-9,16-dihydroxy-4,6,8,18-tetramethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-13-yl]methyl 2-aminobenzoate

C32H46N2O8 (586.3254)


   

bis((5z)-1-acetyl-5-ethylidene-4-hydroxy-3-octanoylpyrrol-2-one)

bis((5z)-1-acetyl-5-ethylidene-4-hydroxy-3-octanoylpyrrol-2-one)

C32H46N2O8 (586.3254)